Meadow Creek Investment Management’s Haemonetics HAE Stock Holding History

Meadow Creek Investment Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.27M	Buy	10,080 +336	+3%	+$42.6K	0.03%	422
2019 Q2	$1.17M	Hold	9,744	–	–	0.02%	447
2019 Q1	$852K	Buy	9,744 +336	+4%	+$30.6K	0.02%	511
2018 Q4	$941K	Hold	9,408	–	–	0.02%	442
2018 Q3	$1.08M	Buy	9,408 +2,072	+28%	+$215K	0.02%	450
2018 Q2	$658K	Hold	7,336	–	–	0.01%	552
2018 Q1	$537K	Hold	7,336	–	–	0.01%	622
2017 Q4	$426K	Buy	7,336 +1,260	+21%	+$66.3K	0.01%	715
2017 Q3	$273K	Buy	6,076 +616	+11%	+$25.6K	0.01%	826
2017 Q2	$216K	Buy	5,460 +2,520	+86%	+$104K	0.01%	853
2017 Q1	$119K	Hold	2,940	–	–	﹤0.01%	890
2016 Q4	$118K	Buy	+2,940	New	+$111K	﹤0.01%	869

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Meadow Creek Investment Management's HAE Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Haemonetics (HAE) stake by 3.4% in Q3 2019, buying an estimated $42.6K and bringing the position to 10,080 shares worth $1.27M. The position accounts for 0.03% of the portfolio, ranked #422.

Meadow Creek Investment Management first reported a position in HAE in Q4 2016 and has held it in 12 quarters since. 275 funds tracked by Wall St. Rank hold HAE as of Q3 2019.

Meadow Creek Investment Management held 10,080 shares of Haemonetics worth $1.27M as of Q3 2019.
Meadow Creek Investment Management bought 336 Haemonetics shares in Q3 2019, an estimated $42.6K.
Haemonetics made up 0.03% of Meadow Creek Investment Management's portfolio in Q3 2019, its #422 holding.
Meadow Creek Investment Management first reported a position in Haemonetics in Q4 2016 and has held it in 12 quarters since.
275 funds tracked by Wall St. Rank held Haemonetics as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.